US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apnimed

17.98

-0.0650-0.36%

Volume:105.83K

Turnover:1.91M

Market Cap:748.31M

PE:4.61

High:18.49

Open:18.05

Low:17.38

Close:18.04

52wk High:35.29

52wk Low:16.12

Shares:41.63M

Float Shares:12.00M

Volume Ratio:0.36

T/O Rate:0.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.90

EPS(LYR):-23.7581

ROE:--

ROA:-36.94%

PB:-4.25

PE(LYR):-0.76

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apnimed: Buy Rating Reiterated on Strong Oxnimbi OSA Profile and Unchanged $50 Price Target

Apnimed Q2 Swings to Earnings, Revenue Declines

MT Newswires Live

Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/APMD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":17.975,"timestamp":1791478337366,"preClose":18.04,"halted":0,"volume":105834,"delay":0,"changeRate":-0.0036031042128601845,"floatShares":12000000,"shares":41630779,"eps":3.898,"marketStatus":"Trading","change":-0.065,"latestTime":"10-08 12:52:53 EDT","open":18.05,"high":18.4881,"low":17.375,"amount":1910720.897628,"amplitude":0.061702,"askPrice":18.14,"askSize":55,"bidPrice":17.81,"bidSize":1,"shortable":3,"etf":0,"ttmEps":3.898,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":18.04,"preHourTrading":{"tag":"盘前","latestPrice":18.03,"preClose":18.04,"latestTime":"09:29 EDT","volume":906,"amount":16336.141266,"timestamp":1791466199999,"change":-0.01,"changeRate":-0.000554,"amplitude":0.018293},"postHourTrading":{"tag":"盘后","latestPrice":18,"preClose":18.04,"latestTime":"19:55 EDT","volume":496,"amount":8968.895,"timestamp":1791417343863,"change":-0.04,"changeRate":-0.002217,"amplitude":0.002217},"volumeRatio":0.360909},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":0.360909,"shares":41630779,"dividePrice":0,"high":18.4881,"amplitude":0.061702,"preClose":18.04,"low":17.375,"week52Low":16.12,"pbRate":"-4.25","psRate":"6.50","week52High":35.29,"institutionHeld":0,"latestPrice":17.975,"committee":-0.964286,"eps":3.898,"divideRate":0,"volume":105834,"delay":0,"ttmEps":3.898,"open":18.05,"prevYearClose":16,"prevWeekClose":21.51,"prevMonthClose":21.91,"prevQuarterClose":21.91,"fiveDayClose":22.54,"twentyDayClose":26.8,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-10-07","current":4.67804,"percent":0.630435,"low":-12.845073,"twenty":-11.861048,"median":-8.277404,"eighty":5.733734,"high":7.380306,"avg":-4.048979,"sd":8.119888,"marketCap":776414028},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874},{"date":"2026-08-28","current":-12.417048,"twenty":-11.890448,"median":-9.403529,"eighty":-8.185761,"marketCap":1591753815},{"date":"2026-09-04","current":-12.023611,"twenty":-12.049552,"median":-9.950282,"eighty":-8.269016,"marketCap":1541318719},{"date":"2026-09-11","current":-8.703457,"twenty":-12.127375,"median":-10.111822,"eighty":-8.343574,"marketCap":1115704877},{"date":"2026-09-18","current":7.153807,"twenty":-12.066846,"median":-9.872618,"eighty":-7.766377,"marketCap":1170241197},{"date":"2026-09-25","current":5.50469,"twenty":-12.02707,"median":-8.703457,"eighty":6.030983,"marketCap":900473749},{"date":"2026-10-02","current":5.736279,"twenty":-11.930224,"median":-8.524375,"eighty":5.874723,"marketCap":938357758},{"date":"2026-10-07","current":4.7463,"twenty":-11.861048,"median":-8.277404,"eighty":5.733734,"marketCap":776414028}],"updateTime":1791473199910},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APMD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672749999","title":"Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749999","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749999?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:05","pubTimestamp":1790971500,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Oct.  02, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374015/0/en/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","APMD","LCLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666499535","title":"Apnimed: Buy Rating Reiterated on Strong Oxnimbi OSA Profile and Unchanged $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666499535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666499535?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:15","pubTimestamp":1788959740,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Apnimed, Inc. today and set a price target of $50.00. Francois Brisebois has ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/apnimed-buy-rating-reiterated-on-strong-oxnimbi-osa-profile-and-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/apnimed-buy-rating-reiterated-on-strong-oxnimbi-osa-profile-and-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370831","title":"Apnimed Q2 Swings to Earnings, Revenue Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370831","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370831?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:52","pubTimestamp":1788900776,"startTime":"0","endTime":"0","summary":"Apnimed (APMD) reported Q2 earnings late Tuesday of $3.91 per diluted share, swinging from a loss of $14.61 a year earlier.Three analysts polled by FactSet expected a loss of $0.49.Revenue for the three months ended June 30 was $12.1 million, down from $17.1 million a year earlier.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666437773","title":"Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M","url":"https://stock-news.laohu8.com/highlight/detail?id=2666437773","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666437773?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:41","pubTimestamp":1788900101,"startTime":"0","endTime":"0","summary":"Apnimed (NASDAQ:APMD) reported quarterly earnings of $3.91 per share which beat the analyst consensus estimate of $(0.34) by 1250 percent.  The company reported $12.080 million in sales this quarter.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61673753/apnimed-q2-eps-3-91-beats-0-34-estimate-sales-12-080m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/APMD\",params:#limit:6,delay:false,,,undefined,":[]}}